Martingale Asset Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.87M | Sell |
14,592
-901
| -6% | -$115K | 0.05% | 318 |
|
|
2025
Q1 | $1.37M | Sell |
15,493
-500
| -3% | -$44.3K | 0.03% | 388 |
|
|
2024
Q4 | $1.39M | Buy |
15,993
+390
| +2% | +$34K | 0.03% | 397 |
|
|
2024
Q3 | $1.44M | Buy |
15,603
+1,098
| +8% | +$102K | 0.03% | 392 |
|
|
2024
Q2 | $1.56M | Buy |
14,505
+490
| +3% | +$52.8K | 0.03% | 356 |
|
|
2024
Q1 | $1.33M | Sell |
14,015
-300
| -2% | -$28.5K | 0.03% | 395 |
|
|
2023
Q4 | $1.32M | Sell |
14,315
-1,798
| -11% | -$166K | 0.03% | 384 |
|
|
2023
Q3 | $809K | Sell |
16,113
-107
| -0.7% | -$5.37K | 0.02% | 498 |
|
|
2023
Q2 | $1.03M | Sell |
16,220
-402
| -2% | -$25.4K | 0.02% | 441 |
|
|
2023
Q1 | $748K | Buy |
+16,622
| New | +$748K | 0.01% | 521 |
|
|
2022
Q1 | – | Sell |
-16,225
| Closed | -$1.74M | – | 809 |
|
|
2021
Q4 | $1.74M | Sell |
16,225
-11,053
| -41% | -$1.18M | 0.02% | 345 |
|
|
2021
Q3 | $2.81M | Buy |
27,278
+12,860
| +89% | +$1.32M | 0.04% | 225 |
|
|
2021
Q2 | $1.27M | Buy |
14,418
+9,807
| +213% | +$863K | 0.01% | 345 |
|
|
2021
Q1 | $449K | Buy |
4,611
+1,104
| +31% | +$108K | 0.01% | 638 |
|
|
2020
Q4 | $394K | Sell |
3,507
-5,596
| -61% | -$629K | ﹤0.01% | 678 |
|
|
2020
Q3 | $844K | Sell |
9,103
-1,400
| -13% | -$130K | 0.01% | 680 |
|
|
2020
Q2 | $820K | Buy |
+10,503
| New | +$820K | 0.01% | 776 |
|